title: [Effect of glucagon-like peptide-1 on hypoxia-reoxygenation induced injury in neonatal rat cardiomyocytes].
abstract: OBJECTIVE
  To observe the effect of glucagon-like peptide-1 (GLP-1) on hypoxia-reoxygenation (H/R) induced injury in neonatal rat cardiomyocytes.
  
  
  METHODS
  Cultured neonatal rat cardiomyocytes were randomly divided into seven groups: normal control group, H/R group, GLP-1 + H/R group, GLP-1 + H/R + UO126 group, GLP-1 + H/R + LY294002 group, H/R + UO126 group, H/R + LY294002 group. LDH activity, apoptosis rate of cardiomyocytes, Caspase-3 activity were detected.
  
  
  RESULTS
  Compared with normal control group, the activity of LDH, cardiomyocyte apoptosis rate, Caspase-3 activity were all significantly increased in H/R group (all P < 0.01). However, compared with H/R group, these changes were significantly attenuated in GLP-1 + H/R group [the activity of LDH (128.47 +/- 7.96) U/L vs. (223.96 +/- 22.10) U/L, P < 0.01, and cardiomyocyte apoptosis rate (2.84 +/- 2.56)% vs. (12.58 +/- 6.69)%, P < 0.01, and Caspase-3 activity (36,809 +/- 4750) RLU vs. (57,602 +/- 9161) RLU, P < 0.01], while LY294002 (PI3K inhibitor) and UO126 (MAPK inhibitor) could block the effects of GLP-1 in cardiomyocytes underwent H/R injury.
  
  
  CONCLUSIONS
  GLP-1 could protect H/R injury mainly by inhibiting cardiomyocytes apoptosis via activating PI3K/Akt and MAPK signaling pathway.
authors.affiliation: Department of Diabetic Neurology, Metabolic Disease Hospital, Tianjin Medical University, Tianjin 300070, China.
authors.forename: Shao-xin
authors.initials: SX
authors.lastname: Wang
authors.forename: Yun
authors.initials: Y
authors.lastname: Xie
authors.forename: Xue
authors.initials: X
authors.lastname: Zhou
authors.forename: Wei-wei
authors.initials: WW
authors.lastname: Sha
authors.forename: Wei-lin
authors.initials: WL
authors.lastname: Wang
authors.forename: Li-ping
authors.initials: LP
authors.lastname: Han
authors.forename: Jia-chi
authors.initials: JC
authors.lastname: Wang
authors.forename: De-min
authors.initials: DM
authors.lastname: Yu
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis / Q000187:drug effects*; D053148:Caspase 3 / Q000378:metabolism; D015687:Cell Hypoxia; D002478:Cells, Cultured; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1 / Q000494:pharmacology*; D015428:Myocardial Reperfusion Injury / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D052216:Glucagon-Like Peptide 1; D005934:Glucagon; C505410:Casp3 protein, rat; D053148:Caspase 3